Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hypertension as a sequela in patients of SARS-CoV-2 infection
Ganxiao Chen, Xun Li, Zuojiong Gong, et al.
PLoS ONE (2021) Vol. 16, Iss. 4, pp. e0250815-e0250815
Open Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)
Zaki A. Sherif, Christian R. Gómez, Thomas J. Connors, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 151
The Protective Effect of Coronavirus Disease 2019 (COVID-19) Vaccination on Postacute Sequelae of COVID-19: A Multicenter Study From a Large National Health Research Network
Sokratis N. Zisis, Jared Durieux, Christian Mouchati, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 7
Open Access | Times Cited: 72
The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication
Qin Ning, Di Wu, Xiaojing Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 70
Preeclampsia and severe acute respiratory syndrome coronavirus 2 infection: a systematic review
Giovanni Tossetta, Sonia Fantone, Nicola delli Muti, et al.
Journal of Hypertension (2022) Vol. 40, Iss. 9, pp. 1629-1638
Open Access | Times Cited: 46
Excess risk for acute myocardial infarction mortality during the COVID‐19 pandemic
Yee Hui Yeo, Maggie Wang, Xinyuan He, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 36
Hypertension management before and under the COVID-19 pandemic: lessons and future directions
Yoichi Nozato, Kōichi Yamamoto, Hiromi Rakugi
Hypertension Research (2023) Vol. 46, Iss. 6, pp. 1471-1477
Open Access | Times Cited: 17
Can adverse cardiac events of the COVID-19 vaccine exacerbate preexisting diseases?
Mohammed S. Razzaque
Expert Review of Anti-infective Therapy (2024) Vol. 22, Iss. 4, pp. 131-137
Closed Access | Times Cited: 5
Impact of breakthrough COVID-19 cases during the omicron wave on vascular health and cardiac autonomic function in young adults
Rachel J. Skow, Damsara Nandadeva, Ann‐Katrin Grotle, et al.
AJP Heart and Circulatory Physiology (2022) Vol. 323, Iss. 1, pp. H59-H64
Open Access | Times Cited: 24
Body composition and cardiorespiratory fitness in overweight or obese people post COVID-19: A comparative study
Maurício Medeiros Lemos, Gustavo Rocha Cavalini, Carlos Renato Pugliese Henrique, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 23
The relationship between COVID-19 vaccines and increased blood pressure: A word of caution
Giacomo Buso, Claudia Agabiti Rosei, María Lorenza Muiesan
European Journal of Internal Medicine (2023) Vol. 111, pp. 27-29
Open Access | Times Cited: 14
Long COVID and risk of erectile dysfunction in recovered patients from mild to moderate COVID-19
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Sumaiah J. Alarfaj, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Oxidative Stress in Arterial Hypertension (HTN): The Nuclear Factor Erythroid Factor 2-Related Factor 2 (Nrf2) Pathway, Implications and Future Perspectives
Daniela Maria Tănase, Alina Georgiana Apostol, Claudia Florida Costea, et al.
Pharmaceutics (2022) Vol. 14, Iss. 3, pp. 534-534
Open Access | Times Cited: 20
Cardiovascular and cerebral vascular health in females with postacute sequelae of COVID-19
Damsara Nandadeva, Rachel J. Skow, Brandi Y. Stephens, et al.
AJP Heart and Circulatory Physiology (2023) Vol. 324, Iss. 6, pp. H713-H720
Open Access | Times Cited: 10
Evaluation of blood pressure variation in recovered COVID-19 patients at one-year follow-up: a retrospective cohort study
Pouria Azami, Reza Golchin Vafa, Reza Heydarzadeh, et al.
BMC Cardiovascular Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Emerging Viral Infections and the Potential Impact on Hypertension, Cardiovascular Disease, and Kidney Disease
Solomiia Savedchuk, Rasha Raslan, Sarah Nystrom, et al.
Circulation Research (2022) Vol. 130, Iss. 10, pp. 1618-1641
Open Access | Times Cited: 18
Impact of COVID-19 on ambulatory blood pressure in young adults: a cross-sectional analysis investigating time since diagnosis
Damsara Nandadeva, Rachel J. Skow, Ann‐Katrin Grotle, et al.
Journal of Applied Physiology (2022) Vol. 133, Iss. 1, pp. 183-190
Open Access | Times Cited: 18
The spike effect of acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 vaccines on blood pressure
Fabio Angeli, Martina Zappa, Gianpaolo Reboldi, et al.
European Journal of Internal Medicine (2022) Vol. 109, pp. 12-21
Open Access | Times Cited: 17
Immune system changes in those with hypertension when infected with SARS-CoV-2
Sheng Su, Ruirong Chen, Shaofen Zhang, et al.
Cellular Immunology (2022) Vol. 378, pp. 104562-104562
Open Access | Times Cited: 16
Racial and ethnic disparities in cardiometabolic disease and COVID-19 outcomes in White, Black/African American, and Latinx populations: Physiological underpinnings
Kanokwan Bunsawat, Gregory J. Grosicki, Soolim Jeong, et al.
Progress in Cardiovascular Diseases (2022) Vol. 71, pp. 11-19
Open Access | Times Cited: 15
Counter-regulatory renin-angiotensin system in hypertension: Review and update in the era of COVID-19 pandemic
Hongyin Chen, Jiangyun Peng, Tengyao Wang, et al.
Biochemical Pharmacology (2022) Vol. 208, pp. 115370-115370
Open Access | Times Cited: 14
The Prevalence of Post-COVID-19 Hypertension in Children
Berfin Uysal, Tuğberk Akça, Okan Akacı, et al.
Clinical Pediatrics (2022) Vol. 61, Iss. 7, pp. 453-460
Open Access | Times Cited: 13
Understanding the role of nACE2 in neurogenic hypertension among COVID-19 patients
Prakash G. Kulkarni, Amul J. Sakharkar, Tanushree Banerjee
Hypertension Research (2021) Vol. 45, Iss. 2, pp. 254-269
Open Access | Times Cited: 16
Literature-Based Discovery to Elucidate the Biological Links between Resistant Hypertension and COVID-19
David Kartchner, Kevin McCoy, Janhvi Dubey, et al.
Biology (2023) Vol. 12, Iss. 9, pp. 1269-1269
Open Access | Times Cited: 6
Faktor-Faktor yang Berhubungan dengan Lama Rawat Inap Pasien COVID-19 di RSUD Serui Provinsi Papua: Studi Potong Lintang
Fahri Ahmad Baihaqi, Henny Rumaropen
Jurnal Penyakit Dalam Indonesia (2022) Vol. 8, Iss. 4, pp. 187-187
Open Access | Times Cited: 10
COVID-19 and diabetes: What do we know so far?
Prakash Gangadaran, Himabindu Padinjarathil, Shri Hari Subhashri Rajendran, et al.
Experimental Biology and Medicine (2022) Vol. 247, Iss. 15, pp. 1330-1334
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top